Cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics
Central Europe and the Baltics: Cause of death, by non-communicable diseases, ages 15-59 was 66.9% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
Central Europe and the Baltics recorded 66.9% for cause of death, by non-communicable diseases, ages 15-59 in 2021. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 10.3% on the previous year and down 15.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics peaked at 80.2% in 2015 and was at its lowest, 66.9%, in 2021.
Central Europe and the Baltics ranks 8th of 47 groups on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 76.5% | — |
| 2010 | 78.9% | +3.1% |
| 2015 | 80.2% | +1.7% |
| 2019 | 79.6% | -0.7% |
| 2020 | 74.5% | -6.4% |
| 2021 | 66.9% | -10.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 76.5% | 76.5% | 76.5% | 1 |
| 2010s | 79.6% | 78.9% | 80.2% | 3 |
| 2020s | 70.7% | 66.9% | 74.5% | 2 |
Countries ranked near Central Europe and the Baltics
More health data for Central Europe and the Baltics
- Population ages 30-34, male, annual growth rate -4.09 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.037 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -1.57 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -1.55 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0319 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, annual growth rate -3.51 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics?
- Cause of death, by non-communicable diseases, ages 15-59 in Central Europe and the Baltics was 66.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Central Europe and the Baltics?
- The highest recorded value was 80.2% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Central Europe and the Baltics?
- The lowest recorded value was 66.9% in 2021.
- How does Central Europe and the Baltics rank for cause of death, by non-communicable diseases, ages 15-59?
- Central Europe and the Baltics ranks 8th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Central Europe and the Baltics?
- Over the last ten years it is down 15.3%. The long-run trend across the full record is falling.
- Where does this Central Europe and the Baltics data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.